TWST (Twist Bioscience) Expected net earnings per share growth this year
Year-over-year EPS growth demonstrates how surging demand for synthetic DNA strands is accelerating ARR, with the magnitude of -64.80 characterizing this level of momentum. Twist Bioscience (TWST) leverages its silicon platform to maintain leadership in biopharma and NGS. The application of semiconductor technologies ensures industrial-scale production while minimizing costs.
Financial and market metric breakdowns for Twist Bioscience (TWST)
- share price and consensus valuation forecast:
- business market valuation indicators:
- shareholders' equity book value data:
- debt and liquidity details:
Total Debt to Equity Ratio Twist Bioscience|TWST - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient twistbioscience.com|TWST - Company Aggregate Debts|Debts to Book Value Twist Bioscience Corp|TWST - Company Long-Term Debt|Company Short-Term Indebtedness Twist Bioscience|Quick Liquidity Indicator twistbioscience.com
- company profitability and valuation multiples indicators:
TWST - Net Profit|Expected Net Profit Twist Bioscience|TWST - Price to Earnings Ratio|Market Cap to Future Earnings Ratio Twist Bioscience Corp|TWST - Price/Earnings to Growth Multiple|Enterprise Value to EBITDA Ratio Twist Bioscience Corp|TWST - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters Twist Bioscience|TWST - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months twistbioscience.com|TWST - Earnings growth in current year|Projected earnings per share growth rate for next year Twist Bioscience
Fundamental valuation:TWST Twist Bioscience Inc
Investors are verifying the financial stability of Twist Bioscience (TWST) through net income dynamics, assessing capital management efficiency and business scalability. By analyzing the annual EPS growth on the GURU.Markets platform, one can determine the monetization rates of automated DNA synthesis and AI-driven microprinting management, where a positive indicator trajectory confirms the successful transition of Twist Bioscience (TWST) from technological development to actual operational profitability.
Main competitors
TEM (Tempus Labs) - Earnings per share growth in current year|QGEN (Qiagen Group) - Earnings growth in current year|Isis Pharmaceuticals (IONS) - Expected net earnings per share growth this year|Earnings per share growth in current year Repligen Corporation (RGEN)|RNA - Earnings per share growth rate in current year|Earnings per share growth in current year CRISPR Therapeutics CRSP|Expected net earnings per share growth this year GeneDx Holdings (WGS)|Ultragenyx Pharma - Earnings growth in current year|Beam Tx (BEAM) - Net earnings per share growth this year|SRPT: Earnings growth in current year|TXG - Expected net earnings per share growth this year|NTLA (Intellia Therapeutics, Inc.) - Earnings growth in current year|Earnings per share growth rate in current year Stoke Therapeutics Inc STOK|Earnings per share growth in current year BioLife Corp (BLFS)|Wave Pharma - Earnings per share growth this year|Earnings growth in current year MAZE (Maze Therapeutics Inc)|SION - Net earnings per share growth this year|Prime Medicine - Earnings growth in current year|Earnings per share growth rate in current year Taysha Gene Therapies Inc|QURE (uniQure Corp) - Net earnings per share growth this year|MGTX: Net earnings per one share growth for the current year|Net earnings per share growth this year RGNX|Net earnings per share growth this year solidbio.com (SLDB)|Earnings per share growth in current year Ocugen (OCGN)|Expected net earnings per share growth this year Pacific Biosciences of California, Inc.|Benitec - Net earnings per share growth this year|Net earnings per one share growth for the current year DSGN (Design Corp)|Rocket Pharmaceuticals - Earnings growth in current year|FDMT (4dmoleculartherapeutics.com) - Earnings per share growth this year|lexeotx.com (LXEO) - Earnings per share growth in current year|Earnings per share growth this year KRRO|EDIT (Editas) - Earnings growth in current year|Earnings growth in current year Silence Therapeutics Corp|Net earnings per share growth this year PRQR (ProQR Therapeutics N.V.)|Net earnings per one share growth for the current year CDXS|Sangamo Therapeutics, Inc. - Net earnings per share growth this year|NAUT - Net earnings per share growth this year|Metagenomi, Inc - Earnings growth in current year|Expected net earnings per share growth this year precisionbiosciences.com DTIL|generationbio.com (GBIO) - Earnings per share growth in current year|BOLD - Expected net earnings per share growth this year|Net earnings per share growth this year XCUR|IMNN (Celsion Corporation) - Net earnings per one share growth for the current year|Net earnings per share growth this year PHIO (Phio Pharmaceuticals)|MBIO (mustangbio.com) - Earnings per share increase in current year|Earnings growth in current year RNAZ (TransCode Therapeutics, Inc.)|Bionano Genomics Inc. - Earnings per share growth in current year|Applied DNA Sciences, Inc. - Earnings growth in current year|Expected net earnings per share growth this year bluebird bio Inc. BLUE|immunoprecise.com (IPA) - Earnings per share growth in current year|Earnings per share growth rate in current year Omega Therapeutics Corp (OMGA)|Earnings per share growth in current year Singular Genomics Systems|regulusrx.com (RGLS) - Expected net earnings per share growth this year|Earnings growth in current year SYRS|Net earnings per share growth this year Telesis Bio Inc. TBIO|Earnings growth in current year TCON (TRACON)|Expected net earnings per share growth this year Unity Biotechnology, Inc (UBX)
